Novacyt S.A.

The company's financials show resilient growth, with revenue advancing from $2.56M in Q4 2022 to $8.29M in Q4 2023. Gross profit remained healthy with margins at -11% in Q4 2023 compared to 30% in Q4 2022. Operating income hit -$11.38M last quarter, sustaining a consistent -137% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at -$8.37M. Net income dropped to -$20.07M, while earnings per share reached -$0.33. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.